OBJECTIVE: To delineate the natural history, diagnosis, and treatment response of Parkinson disease (PD) in individuals with 22q11.2 deletion syndrome (22q11.2DS), and to determine if these patients differ from those with idiopathic PD. METHODS: In this international observational study, we characterized the clinical and neuroimaging features of 45 individuals with 22q11.2DS and PD (mean follow-up 7.5 ± 4.1 years). RESULTS: 22q11.2DS PD had a typical male excess (32 male, 71.1%), presentation and progression of hallmark motor symptoms, reduced striatal dopamine transporter binding with molecular imaging, and initial positive response to levodopa (93.3%). Mean age at motor symptom onset was relatively young (39.5 ± 8.5 years); 71.4% of cases...
Background: 22q11.2 deletion syndrome (22q11.2DS) is considered as the genetic model of schizophreni...
The 22q11 deletion syndrome (22q11DS) is one of the most common genomic disorders in humans. There i...
To investigate disease risk mechanisms of early-onset Parkinson's disease (PD) associated with the r...
OBJECTIVE: To delineate the natural history, diagnosis, and treatment response of Parkinson disease ...
International audienceBackground. - While it is known that 22q11.2 microdeletions (22q11.2-del) incr...
Background: The recurrent hemizygous 22q11.2 deletion associated with 22q11.2 deletion syndrome has ...
Background: 22q11.2 deletion syndrome (22q11.2DS) is a multisystem condition associated with an incr...
The etiology of Parkinson’s disease (PD) remains largely unknown with the exception of a few genetic...
Background Parkinson's disease has been reported in a small number of patients with chromosome 22q11...
22q11.2 microdeletions are among the most common deletions found in humans. Whereas most cases prese...
Background: 22q11.2 deletion syndrome (22q11.2DS) is considered as the genetic model of schizophreni...
The 22q11 deletion syndrome (22q11DS) is one of the most common genomic disorders in humans. There i...
To investigate disease risk mechanisms of early-onset Parkinson's disease (PD) associated with the r...
OBJECTIVE: To delineate the natural history, diagnosis, and treatment response of Parkinson disease ...
International audienceBackground. - While it is known that 22q11.2 microdeletions (22q11.2-del) incr...
Background: The recurrent hemizygous 22q11.2 deletion associated with 22q11.2 deletion syndrome has ...
Background: 22q11.2 deletion syndrome (22q11.2DS) is a multisystem condition associated with an incr...
The etiology of Parkinson’s disease (PD) remains largely unknown with the exception of a few genetic...
Background Parkinson's disease has been reported in a small number of patients with chromosome 22q11...
22q11.2 microdeletions are among the most common deletions found in humans. Whereas most cases prese...
Background: 22q11.2 deletion syndrome (22q11.2DS) is considered as the genetic model of schizophreni...
The 22q11 deletion syndrome (22q11DS) is one of the most common genomic disorders in humans. There i...
To investigate disease risk mechanisms of early-onset Parkinson's disease (PD) associated with the r...